BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19455474)

  • 1. Multiple myeloma.
    Baur-Melnyk A; Reiser MF
    Semin Musculoskelet Radiol; 2009 Jun; 13(2):111-9. PubMed ID: 19455474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography].
    Baur-Melnyk A; Reiser M
    Radiologe; 2004 Sep; 44(9):874-81. PubMed ID: 15365631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging in multiple myeloma.
    Delorme S; Baur-Melnyk A
    Recent Results Cancer Res; 2011; 183():133-47. PubMed ID: 21509684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
    Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
    AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging in multiple myeloma.
    Delorme S; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.
    Lütje S; de Rooy JW; Croockewit S; Koedam E; Oyen WJ; Raymakers RA
    Ann Hematol; 2009 Dec; 88(12):1161-8. PubMed ID: 19763570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of imaging techniques in the management of multiple myeloma.
    Zamagni E; Cavo M
    Br J Haematol; 2012 Dec; 159(5):499-513. PubMed ID: 22881361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of FDG PET in the assessment of patients with multiple myeloma.
    Bredella MA; Steinbach L; Caputo G; Segall G; Hawkins R
    AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Body MRI versus PET in assessment of multiple myeloma disease activity.
    Shortt CP; Gleeson TG; Breen KA; McHugh J; O'Connell MJ; O'Gorman PJ; Eustace SJ
    AJR Am J Roentgenol; 2009 Apr; 192(4):980-6. PubMed ID: 19304704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
    Wolf MB; Murray F; Kilk K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
    Eur J Radiol; 2014 Jul; 83(7):1222-1230. PubMed ID: 24793843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone disease in multiple myeloma. A study of 237 cases].
    Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
    Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body imaging of bone marrow.
    Schmidt GP; Reiser MF; Baur-Melnyk A
    Semin Musculoskelet Radiol; 2009 Jun; 13(2):120-33. PubMed ID: 19455475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Whole Body Magnetic Resonance and CT/PET in patients affected by multiple myeloma during staging before treatment].
    Falcone C; Cipullo S; Sannino P; Restuccia A
    Recenti Prog Med; 2012 Nov; 103(11):444-9. PubMed ID: 23096729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging and PET/CT in diagnosis and management of multiple myeloma.
    Ferraro R; Agarwal A; Martin-Macintosh EL; Peller PJ; Subramaniam RM
    Radiographics; 2015; 35(2):438-54. PubMed ID: 25763728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Becker C; Schoenberg SO; Lang N; Bartl R; Reiser MF
    AJR Am J Roentgenol; 2008 Apr; 190(4):1097-104. PubMed ID: 18356461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
    Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
    In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.